BeStock  
Stocks › Biotechnology › FDMT

4D Molecular Therapeutics FDMT

US equityMarket cap rank #3512Biotechnology
$10.23 −$0.49 (-4.57%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $10.23 0.00%
Open$10.36
Prev close$10.72
Day range$10.11 – $10.94
Volume691.0K
Market cap$576.76M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership109.2%+2.08 pts vs. prior quarter
Institutions holding196+8 vs. prior quarter
Insider trades (recent)19 buys / 26 sellsNet selling
Short interest19.73% of floatDays to cover 10.4 · as of 30 Oct 2026
Short-sale volume share14.5%5-day average of daily volume

Short-sale volume as % of daily volume

10%19%29%39%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$3.05M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

+$1.6MSuper+$1.5MBig+$2.0MMid+$770.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 40.9% of shares outstanding.

Largest holders

  • Janus Henderson Group plc10.40%
  • RA Capital Management, L.P.9.14%
  • BlackRock8.55%
  • The Goldman Sachs Group, Inc.6.95%
  • Novo Holdings A/S5.88%
  • BVF Partners L.P.5.21%
  • T. Rowe Price Group, Inc.4.65%
  • State Street Global Advisors4.47%

By investor type

  • Mutual Fund50.99%
  • Hedge Fund26.58%
  • VC/PE Fund17.60%
  • Public Company11.11%
  • Individual/Insider2.74%
  • Private Company1.69%
  • Insurance Company0.89%
  • Government Pension Fund0.25%

Reported short interest has fallen from 22.25% to 19.73% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Morgan Stanley Public Company 2026/Q3 +587,629 2.0%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +587,629 2.0%
FMR Mutual Fund 2026/Q3 +183,602 0.6%
BlackRock Mutual Fund 2026/Q3 +178,845 8.6%
Jane Street Group, LLC Private Company 2026/Q3 +171,009 0.3%
Barclays PLC Public Company 2026/Q3 +157,371 0.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +2,524,309 4.6%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +925,000 4.0%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +644,047 4.0%
Diadema Partners LP Hedge Fund 2026/Q3 +571,107 1.0%
Janus Henderson Group plc Mutual Fund 2026/Q3 +499,138 10.2%
Catalio Capital Management, LP VC/PE Fund 2026/Q3 +471,254 0.8%
Parkman Healthcare Partners LLC Hedge Fund 2026/Q3 +425,607 1.7%
Citadel Advisors LLC Hedge Fund 2026/Q3 +423,501 1.2%
BlackRock Mutual Fund 2026/Q3 +400,756 8.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
15 Oct 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -1,635 $12.84 8,617
4 Oct 2026 David Kirn Chief Executive Officer Automatic Disposition -58,333 $13.61 1,309,153
4 Oct 2026 David Kirn Chief Executive Officer Intent to Sell (Form 144) -58,333 $12.92 –
15 Sep 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -1,635 $13.65 8,617
13 Sep 2026 David Kirn Chief Executive Officer Automatic Disposition -58,333 $13.90 1,367,486
31 Aug 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -584 $14.00 8,617
18 Aug 2026 David Kirn Chief Executive Officer Automatic Disposition -19,076 $16.42 1,425,819
18 Aug 2026 David Kirn Chief Executive Officer Derivative Exercise and Sale -50,000 $16.42 1,425,819
16 Aug 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -3,270 $12.20 8,617
3 Aug 2026 David Kirn Chief Executive Officer Automatic Disposition -26,842 $10.23 1,444,895
2 Aug 2026 David Kirn Chief Executive Officer Automatic Disposition -12,415 $10.05 1,471,737
9 Jul 2026 David Kirn Chief Executive Officer Intent to Sell (Form 144) -15,725 $12.31 –
9 Jul 2026 David Kirn Chief Executive Officer Open Market Disposition -58,333 $12.87 1,484,152
8 Jul 2026 David Kirn Chief Executive Officer Intent to Sell (Form 144) -42,608 $12.89 –
29 Jun 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -6,566 $14.00 8,617
22 Jun 2026 Scott Bizily Chief Legal Officer Derivative Exercise and Sale -9,810 $12.00 8,617
21 Jun 2026 David Kirn Chief Executive Officer Automatic Disposition -114,746 $10.47 1,542,485
16 Jun 2026 Glenn Sblendorio Director Other Derivative Acquisition +50,000 $9.42 50,000
16 Jun 2026 John Milligan Executive Chairperson Other Derivative Acquisition +75,000 $9.42 75,000
16 Jun 2026 Charles Theuer Independent Director Other Derivative Acquisition +50,000 $9.42 50,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 10,897,478 19.7% 10.4
15 Oct 2026 11,530,134 20.9% 12.0
30 Sep 2026 11,238,611 20.3% 9.3
15 Sep 2026 12,008,645 21.7% 18.6
31 Aug 2026 12,069,229 21.8% 8.1
14 Aug 2026 12,289,621 22.2% 22.3

Discussion

No comments yet — be the first to weigh in on FDMT.

Sign in to join the discussion.

Scroll to Top